当前位置:首页 > 报告详情

ANDA 错过目标日期-Sherwood.pdf

上传人: 哆哆 编号:631071 2025-04-19 37页 426.36KB

1、ANDA Missed Goal DatesEdward SherwoodOffice of Regulatory OperationsOffice of Generic DrugsCenter for Drug Evaluation and ResearchApril 9,2025fda.gov/cdersbia2Learning Objectives Describe a missed goal date What happens with a miss Causes of missed goal dates Public informationfda.gov/cdersbia3 FDA

2、hears frustration with misses FDA apologizes for misses FDA does not like misses FDA never gives up on an ANDABackgroundfda.gov/cdersbia4 Completion and communication dateAll discipline assessmentsAll facility evaluations(includes inspections and equivalents)Letter issued What is a Goal Date?fda.gov

3、/cdersbia5 Assessors&PMs want approvals Approvals often easier for assessors FDA wants high approval counts FDA desires approvals on the earliest lawful approval date(ELAD)FDA mandates appropriate approvals Goal Dates Not Approval Datesfda.gov/cdersbia6 FDA did not complete and communicate by the cu

4、rrent goal dateMay include extensions(noted in Acknowledgement Letters)May be the longer of two goal dates from Acknowledgement LetterWhat is a Goal Date Missfda.gov/cdersbia7Acknowledgement Letter“the GDUFA goal date for review of this priority major amendment is June 20,2024.If FDA determines that

5、 an inspection is required to validate the information contained in this priority major amendment and a Pre-Submission Facility Correspondence was not submitted or not accepted,the GDUFA goal date for review of this priority major amendment is October 20,2024.”fda.gov/cdersbia8Acknowledgement Letter

6、(cont.)“.the GDUFA goal dateis June 20,2024.If FDA determines that an inspection is requiredthe GDUFA goal date for review of this priority major amendment is October 20,2024.”Oct.1 AP(with inspection/equivalent)is a make!Oct.31 CRL is a miss Oct.31 AP is a make!(Imminent Action)AP=Approval CRL=Comp

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文主要介绍了美国食品药品监督管理局(FDA)在审批 generic drugs(仿制药)过程中,针对 Abbreviated New Drug Application(ANDA,简化新药申请)的 goal dates(目标日期)的执行情况及相关的数据统计。 关键数据有: 1. 2024年6月20日,有105个ANDA的目标日期。 2. 2024年10月20日,有101个ANDA的目标日期。 3. 在这些目标日期中,有83个ANDA获得了批准或者临时批准,36个ANDA获得了临时批准。 主要内容概括如下: 1. FDA在审批ANDA时,会设定一个目标日期,即期望完成审批的时间。 2. 如果FDA在目标日期前完成了审批,则认为该目标日期得到了满足。 3. 如果FDA在目标日期后完成了审批,则认为发生了missed goal date(错过目标日期)。 4. 错过目标日期可能会导致一系列的后果,如可能导致ANDA的审批延迟,或者影响到其他ANDA的审批工作。 5. 文章最后提醒,现在是一个提交ANDA的好时机。
"错过目标日期后,FDA会怎么做?" "紧急行动是如何报告的?" "在目标日期后60天内获得ANDA AP或TA是否算作达标?"
客服
商务合作
小程序
服务号
折叠